Explore practical health tips, the latest medical news, and expert wellness advice to help you maintain a balanced and healthy lifestyle every day.
(MedPage Today) — Kennedy’s surgeon general nominee is facing scrutiny over some products she has sold. Casey Means, MD, has been accused of selling numerous unsafe products. Some contain hazardous...
(MedPage Today) — The nation’s safest hospitals, according to annual rankings from Healthgrades, represent the top 10% of hospitals nationwide for patient safety, with the lowest incidences of 13 preventable...
(MedPage Today) — The obesity drug semaglutide (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis...
(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA’s handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD)...
(MedPage Today) — A single high-strength dose of psilocybin was more effective than nicotine patches for helping smokers quit, a pilot randomized trial showed. When added to cognitive behavioral therapy...
(MedPage Today) — With the help of artificial intelligence (AI), routine screening mammograms could identify women at higher cardiovascular risk, a retrospective cohort study suggested. A greater amount of AI-calculated...
(MedPage Today) — The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced. The company also...
(MedPage Today) — For people with exertional-only hypoxemia from fibrotic interstitial lung disease (ILD), use of a portable oxygen concentrator didn’t increase physical activity in daily life compared with room...
(MedPage Today) — The use of neoadjuvant chemotherapy failed to improve disease-free survival (DFS) over upfront surgery in patients with locally advanced colon cancer, a phase III randomized trial showed....
(MedPage Today) — Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly reduced the risk of disease progression or death in metastatic...
